Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  HeartWare International Inc    HTWR

Delayed Quote. Delayed  - 06/24 10:00:00 pm
29.98 USD   -9.56%
06/01 HEARTWARE : Presentation At The Goldman Sachs 37th Annual Global Hea..
05/05 HEARTWARE : Presentation At The Bank Of America Merrill Lynch 2016 H..
05/04 HEARTWARE : reports 1Q loss
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

HEARTWARE INTERNATIONAL, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/06/2016 | 10:14pm CEST

Item 5.07 Submission of Matters to a Vote of Security Holders

On Thursday, June 2, 2016, HeartWare International, Inc. (the "company") held its Annual Meeting of Stockholders at its corporate headquarters in Framingham, Massachusetts. The company stockholders approved each of the proposals put to a vote as recommended by the company's Board of Directors. The proposals had been previously announced and described in the Notice of Meeting contained in the company's Definitive Proxy Statement, which was filed with the Securities and Exchange Commission on April 29, 2016. Of the 17,536,482 shares of the company's outstanding common stock entitled to vote at the meeting, 16,257,345 shares of common stock, or approximately 92.71%, were represented at the meeting in person or by proxy.

The proposals voted upon and approved by the stockholders of the company were as follows:



    1.  To elect each of Chadwick Cornell, Douglas Godshall, Seth Harrison, M.D.
        and Robert Stockman as a Class II Director to hold office until the
        company's Annual Meeting of Stockholders to be held in 2019, or until a
        successor is duly elected and qualified, and to elect Stephen Oesterle,
        M.D. as a Class I Director to hold office until the company's Annual
        Meeting of Stockholders to be held in 2018, or until a successor is duly
        elected and qualified;




    2.  To ratify the appointment of Grant Thornton LLP as the company's
        independent registered public accounting firm for the fiscal year ending
        December 31, 2016; and




    3.  To consider and act on an advisory vote to approve the compensation paid
        to certain executive officers.

A tabular summary of the voting results is attached as an exhibit and is incorporated by reference into this Item 5.07.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits




Exhibit No.       Description

99.1              Tabular Summary of Voting Results from HeartWare's June 2, 2016
                  Annual Meeting of Stockholders

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on HEARTWARE INTERNATIONAL IN
06/06 HEARTWARE INTERNATIONAL, INC. : Submission of Matters to a Vote of Security Hold..
06/01 HEARTWARE : Presentation At The Goldman Sachs 37th Annual Global Healthcare Conf..
05/18 HEARTWARE : Assigned Patent
05/05 HEARTWARE : Presentation At The Bank Of America Merrill Lynch 2016 Health Care C..
05/04 HEARTWARE : reports 1Q loss
05/04 HEARTWARE INTERNATIONAL, INC. : Results of Operations and Financial Condition, F..
05/04 HEARTWARE : Reports First Quarter 2016 Financial Results
05/04 HEARTWARE : Reports First Quarter 2016 Financial Results
04/27 HEARTWARE : Completes Enrollment In HVAD® System LATERAL Study™
04/27 HEARTWARE : Completes Enrollment In HVAD® System LATERAL Study(TM)
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials